Page 18 - TD-3-2

Tumor Discovery Volatile organic compounds for cancer screening

3. Nakhleh MK, Amal H, Jeries R, et al. Diagnosis and doi: 10.1111/jrh.12308
classification of 17 diseases from 1404 subjects via pattern 15. O’Hara J, McPhee C, Dodson S, et al. Barriers to breast cancer
analysis of exhaled molecules. ACS Nano. 2017;11(1):112-125. screening among diverse cultural groups in Melbourne,
doi: 10.1021/acsnano.6b04930 Australia. Int J Environ Res Public Health. 2018;15(8):1677.
4. Einoch Amor R, Nakhleh MK, Barash O, Haick H. Breath doi: 10.3390/ijerph15081677
analysis of cancer in the present and the future. Eur Respir 16. Rim SH, Allaire BT, Ekwueme DU, et al. Cost-effectiveness
Rev. 2019;28(152):190002. of breast cancer screening in the National Breast and
doi: 10.1183/16000617.0002-2019 Cervical Cancer Early Detection Program. Cancer Causes
Control. 2019;30(8):819-826.
5. Serasanambati M, Broza YY, Marmur A, Haick H. Profiling
single cancer cells with volatolomics approach. iScience. doi: 10.1007/s10552-019-01178-y
2019;11:178-188. 17. Vahabi M, Lofters A, Kumar M, Glazier RH. Breast cancer
doi: 10.1016/j.isci.2018.12.008 screening disparities among immigrant women by world
region of origin: A population-based study in Ontario,
6. Hanahan D, Weinberg RA. Hallmarks of cancer: The next Canada. Cancer Med. 2016;5(7):1670-1686.
generation. Cell. 2011;144(5):646-674.
doi: 10.1002/cam4.700
doi: 10.1016/j.cell.2011.02.013
18. Patterson SG, Bayer CW, Hendry RJ, et al. Breath analysis by
7. Arnold M, Morgan E, Rumgay H, et al. Current and future mass spectrometry: A new tool for breast cancer detection?
burden of breast cancer: Global statistics for 2020 and 2040. Am Surg. 2011;77(6):747-751.
Breast. 2022;66:15-23.
doi: 10.1177/0003134811077006
doi: 10.1016/j.breast.2022.08.010
19. Phillips M, Cataneo RN, Saunders C, Hope P, Schmitt P, Wai J.
8. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer Volatile biomarkers in the breath of women with breast
incidence and mortality rates and trends--an update. Cancer cancer. J Breath Res. 2010;4(2):026003.
Epidemiol Biomarkers Prev. 2016;25(1):16-27.
doi: 10.1088/1752-7155/4/2/026003
doi: 10.1158/1055-9965.EPI-15-0578
20. Li J, Peng Y, Liu Y, et al. Investigation of potential breath
9. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, biomarkers for the early diagnosis of breast cancer using
2023. CA Cancer J Clin. 2023;73(1):17-48. gas chromatography-mass spectrometry. Clin Chim Acta.
2014;436:59-67.
doi: 10.3322/caac.21763
doi: 10.1016/j.cca.2014.04.030
10. Breast Cancer Surveillance Consortium, Funded by the
National Cancer Institute; 2021. Available from: https:// 21. Yazdanpanah M, Luo X, Lau R, Greenberg M, Fisher LJ,
breastscreening.cancer.gov [Last accessed on 2023 Jul 01]. Lehotay DC. Cytotoxic aldehydes as possible markers for
childhood cancer. Free Radic Biol Med. 1997;23(6):870-878.
11. Tabár L, Dean PB, Chen TH, et al. The incidence of fatal
breast cancer measures the increased effectiveness of therapy doi: 10.1016/s0891-5849(97)00070-1
in women participating in mammography screening. 22. Hamel E, Lin CM, Plowman J, Wang HK, Lee KH, Paull
Cancer. 2019;125(4):515-523. KD. Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone
doi: 10.1002/cncr.31840 derivatives. Interactions with tubulin. Biochem Pharmacol.
1996;51(1):53-59.
12. Phillips M, Cataneo RN, Ditkoff BA, et al. Prediction of
breast cancer using volatile biomarkers in the breath. Breast doi: 10.1016/0006-2952(95)02156-6
Cancer Res Treat. 2006;99(1):19-21. 23. Mukherjee S, Kumar V, Prasad AK, et al. Synthetic
doi: 10.1007/s10549-006-9176-1 and biological activity evaluation studies on novel
1,3-diarylpropenones. Bioorg Med Chem. 2001;9(2):337-345.
13. Akinyemiju T, Ogunsina K, Sakhuja S, Ogbhodo V,
Braithwaite D. Life-course socioeconomic status and breast doi: 10.1016/s0968-0896(00)00249-2
and cervical cancer screening: Analysis of the WHO’s Study 24. Phillips M, Altorki N, Austin JHM, et al. Detection of lung
on Global Ageing and Adult Health (SAGE). BMJ Open. cancer using weighted digital analysis of breath biomarkers.
2016;6(11):e012753. Clin Chim Acta. 2008;393(2):76-84.
doi: 10.1136/bmjopen-2016-012753 doi: 10.1016/j.cca.2008.02.021
14. Chandak A, Nayar P, Lin G. Rural-urban disparities in access 25. Arnold M, Sierra MS, Laversanne M, Soerjomataram I,
to breast cancer screening: A Spatial clustering analysis. Jemal A, Bray F. Global patterns and trends in colorectal
J Rural Health. 2019;35(2):229-235. cancer incidence and mortality. Gut. 2017;66(4):683-691.

Volume 3 Issue 2 (2024) 12 doi: 10.36922/td.2061